Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    July 2022
  1. MARTIN A, Isakova T
    Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease-mineral and bone disorder.
    Curr Opin Nephrol Hypertens. 2022;31:303-305.
    PubMed    


    June 2022
  2. DUQUE EJ, Elias RM, Moyses RMA
    Phosphate balance during dialysis and after kidney transplantation in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00008.
    PubMed     Abstract available


  3. AGORO R, White KE
    Anemia and fibroblast growth factor 23 elevation and chronic kidney disease: homeostatic interactions and emerging therapeutics.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00005.
    PubMed     Abstract available


  4. SMOUT D, Jorgensen HS, Cavalier E, Evenepoel P, et al
    Clinical utility of bone turnover markers in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00002.
    PubMed     Abstract available


  5. DORR K, Kainz A, Oberbauer R
    Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Jun 13. pii: 00041552-990000000-00001.
    PubMed     Abstract available


    March 2022
  6. WEINHANDL ED
    The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated.
    Curr Opin Nephrol Hypertens. 2022;31:185-190.
    PubMed     Abstract available


    February 2022
  7. CANNEY M, Sood MM, Hundemer GL
    Contemporary risk prediction models in chronic kidney disease: when less is more.
    Curr Opin Nephrol Hypertens. 2022 Feb 25. pii: 00041552-900000000-98931.
    PubMed     Abstract available


  8. TANGRI N, Ferguson TW
    Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury.
    Curr Opin Nephrol Hypertens. 2022 Feb 21. pii: 00041552-900000000-98932.
    PubMed     Abstract available


  9. RAJ R
    Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2022 Feb 14. pii: 00041552-900000000-98934.
    PubMed     Abstract available


  10. TAN H, Xu J, Liu Y
    Ageing, cellular senescence and chronic kidney disease: experimental evidence.
    Curr Opin Nephrol Hypertens. 2022 Feb 9. pii: 00041552-900000000-98935.
    PubMed     Abstract available


    January 2022
  11. MUREA M, Flythe JE, Anjay R, Emaad AM, et al
    Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one.
    Curr Opin Nephrol Hypertens. 2022;31:92-99.
    PubMed     Abstract available


  12. SUMIDA K, Lau WL, Kalantar-Zadeh K, Kovesdy CP, et al
    Novel intestinal dialysis interventions and microbiome modulation to control uremia.
    Curr Opin Nephrol Hypertens. 2022;31:82-91.
    PubMed     Abstract available


  13. TANTISATTAMO E, Hanna RM, Kalantar-Zadeh K
    Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
    Curr Opin Nephrol Hypertens. 2022;31:1-5.
    PubMed    


    December 2021
  14. BLEYER AJ
    Factors that lead to dialysis as the preferred treatment modality for patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Dec 24. pii: 00041552-900000000-98940.
    PubMed     Abstract available


  15. LEON SJ, Tangri N
    Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2021 Dec 24. pii: 00041552-900000000-98941.
    PubMed     Abstract available


    November 2021
  16. OTOBE Y, Rhee CM, Nguyen M, Kalantar-Zadeh K, et al
    Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.
    Curr Opin Nephrol Hypertens. 2021 Nov 11. pii: 00041552-900000000-98950.
    PubMed     Abstract available


  17. AHDOOT RS, Kalantar-Zadeh K, Burton JO, Lockwood MB, et al
    Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98960.
    PubMed     Abstract available


  18. KALANTAR-ZADEH K, Rhee CM, Joshi S, Brown-Tortorici A, et al
    Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98952.
    PubMed     Abstract available


  19. TANTISATTAMO E, Hamiduzzaman A, Sohn P, Ahdoot R, et al
    Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98955.
    PubMed     Abstract available


  20. TANTISATTAMO E, Kalantar-Zadeh K, Molnar MZ
    Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98954.
    PubMed     Abstract available


  21. RHEE CM, Kalantar-Zadeh K, Tuttle KR
    Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98953.
    PubMed     Abstract available


  22. ALSAAD R, Chen X, McAdams-DeMarco M
    The clinical application of frailty in nephrology and transplantation.
    Curr Opin Nephrol Hypertens. 2021;30:593-599.
    PubMed     Abstract available


  23. STEWART P, Stewart J
    Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability.
    Curr Opin Nephrol Hypertens. 2021;30:559-562.
    PubMed     Abstract available


    September 2021
  24. CANAUD B
    Recent advances in dialysis membranes.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98966.
    PubMed     Abstract available


  25. ZABETIAN A, Coca SG
    Plasma and urine biomarkers in chronic kidney disease: closer to clinical application.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98967.
    PubMed     Abstract available


    August 2021
  26. TIAN N, Chen N, Li PK
    Depression in dialysis.
    Curr Opin Nephrol Hypertens. 2021 Aug 26. pii: 00041552-900000000-98971.
    PubMed     Abstract available


  27. LIGHTFOOT CJ, Howell M, Smith AC
    How to assess quality of life in persons with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Aug 23. pii: 00041552-900000000-98972.
    PubMed     Abstract available


    July 2021
  28. SINHA S, Raggi P, Chertow GM
    SNF472: mechanism of action and results from clinical trials.
    Curr Opin Nephrol Hypertens. 2021;30:424-429.
    PubMed     Abstract available


    June 2021
  29. SAEED F, Shah AY, Allen RJ, Epstein RM, et al
    Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature.
    Curr Opin Nephrol Hypertens. 2021 Jun 18. pii: 00041552-900000000-98977.
    PubMed     Abstract available


    May 2021
  30. COHEN-BUCAY A, Francis JM, Gordon CE
    Progress in hepatitis C virus management in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 28. pii: 00041552-900000000-98979.
    PubMed     Abstract available


  31. PARVATHAREDDY VP, Ella KM, Shah M, Navaneethan SD, et al
    Treatment options for managing obesity in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 25. pii: 00041552-900000000-98980.
    PubMed     Abstract available


  32. SMEIJER JD, Kohan DE, Webb DJ, Dhaun N, et al
    Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 10. pii: 00041552-900000000-98984.
    PubMed     Abstract available


  33. CHALUPSKY M, Goodson DA, Gamboa JL, Roshanravan B, et al
    New insights into muscle function in chronic kidney disease and metabolic acidosis.
    Curr Opin Nephrol Hypertens. 2021;30:369-376.
    PubMed     Abstract available


  34. VLASSCHAERT C, Sidhu B, Silver SA
    Sodium/glucose cotransporter 2 inhibitors in chronic kidney disease and heart failure: ready for prime time in patients without diabetes.
    Curr Opin Nephrol Hypertens. 2021;30:361-368.
    PubMed     Abstract available


  35. ARIF H, Yadav A
    Approach to stable angina in patients with advanced chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021;30:339-345.
    PubMed     Abstract available


    April 2021
  36. DAMRATH JG, Creecy A, Wallace JM, Moe SM, et al
    The impact of advanced glycation end products on bone properties in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Apr 28. pii: 00041552-900000000-98985.
    PubMed     Abstract available


    January 2021
  37. CLARK-CUTAIA MN, Rivera E, Iroegbu C, Squires A, et al
    Disparities in chronic kidney disease-the state of the evidence.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99003.
    PubMed     Abstract available


  38. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    PubMed     Abstract available


  39. PREMACHANDRA KH, Day RO, Roberts DM
    Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum.
    Curr Opin Nephrol Hypertens. 2021;Publish Ahead of Print.
    PubMed     Abstract available


    December 2020
  40. NAIR D, Malhotra S, Lupu D, Harbert G, et al
    Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  41. SOOMRO QH, Charytan DM
    Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  42. ZARANTONELLO D, Rhee CM, Kalantar-Zadeh K, Brunori G, et al
    Novel conservative management of chronic kidney disease via dialysis-free interventions.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000670.
    PubMed     Abstract available


  43. TANTISATTAMO E, Kalantar-Zadeh K
    Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000677.
    PubMed    


  44. STREJA E, Norris KC, Budoff MJ, Hashemi L, et al
    The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000672.
    PubMed     Abstract available


  45. FERREY AJ, Hanna R, Reddy UG, Tantisattamo E, et al
    Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000671.
    PubMed     Abstract available


  46. TANTISATTAMO E, Leventhal JR, Mathew JM, Gallon L, et al
    Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000666.
    PubMed     Abstract available


  47. HANNA RM, Ferrey A, Rhee CM, Sam R, et al
    Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000658.
    PubMed     Abstract available


  48. TANTISATTAMO E, Kalantar-Zadeh K, Halleck F, Duettmann W, et al
    Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000673.
    PubMed     Abstract available


  49. ONG SC, Rhee CM
    Novel management of diabetes in kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000665.
    PubMed     Abstract available


  50. MUREA M
    Precision medicine approach to dialysis including incremental and decremental dialysis regimens.
    Curr Opin Nephrol Hypertens. 2020 Nov 6. doi: 10.1097/MNH.0000000000000667.
    PubMed     Abstract available


  51. SUMIDA K, Lau WL, Kovesdy CP, Kalantar-Zadeh K, et al
    Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000661.
    PubMed     Abstract available


  52. JUDGE PK, Haynes R
    taleNeprilysin and Neprilysin inhibition in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000659.
    PubMed     Abstract available


  53. HUR L, McIntyre CW
    Current and novel imaging techniques to evaluate myocardial dysfunction during hemodialysis.
    Curr Opin Nephrol Hypertens. 2020;29:555-563.
    PubMed     Abstract available


  54. CHUKWU CA, Middleton R, Kalra PA
    Recurrent glomerulonephritis after renal transplantation.
    Curr Opin Nephrol Hypertens. 2020;29:636-644.
    PubMed     Abstract available


  55. VIRAMONTES-HORNER D, Taal MW
    Nutritional status assessment: a neglected biomarker in persons with end-stage kidney disease.
    Curr Opin Nephrol Hypertens. 2020;29:547-554.
    PubMed     Abstract available


    January 2020
  56. KELLER RW JR, Kopple JD, Kalantar-Zadeh K
    Perspiration interventions for conservative management of kidney disease and uremia.
    Curr Opin Nephrol Hypertens. 2020;29:57-63.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: